{"name": "Orteq",
 "permalink": "orteq",
 "crunchbase_url": "http://www.crunchbase.com/company/orteq",
 "homepage_url": "http://orteq.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@orteq.com",
 "phone_number": "44-207-960-6070",
 "description": "",
 "created_at": "Thu Jan 13 11:58:40 UTC 2011",
 "updated_at": "Thu Jan 13 12:21:18 UTC 2011",
 "overview": "\u003Cp\u003EOrteq Ltd, with headquarters in London, UK and manufacturing, R/ D in Groningen, the Netherlands, was established in 2005 to develop and commercialize bioengineering solutions for orthopaedic injuries. Orteq has developed a biodegradable, biocompatible polymer implant, Actifit, specifically designed to promote tissue ingrowth and regeneration in the meniscus, a fibrocartilage cushion in the knee. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       49],
      "assets/images/resized/0011/7146/117146v1-max-150x150.jpg"],
     [[250,
       82],
      "assets/images/resized/0011/7146/117146v1-max-250x250.jpg"],
     [[368,
       121],
      "assets/images/resized/0011/7146/117146v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/01/orteq-sports-medicine-receives-minority.html",
    "source_description": "Orteq Sports Medicine Receives Minority Equity Investment from Kensey Nash Corporation",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2011,
    "funded_month": 1,
    "funded_day": 8,
    "investments":
     [{"company":
        {"name": "Kensey Nash Corporation",
         "permalink": "kensey-nash-corporation",
         "image":
          {"available_sizes":
            [[[150,
               45],
              "assets/images/resized/0011/7149/117149v1-max-150x150.jpg"],
             [[250,
               75],
              "assets/images/resized/0011/7149/117149v1-max-250x250.jpg"],
             [[279,
               84],
              "assets/images/resized/0011/7149/117149v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "10 Greycoat Place",
    "address2": "",
    "zip_code": "SW1P 1SB",
    "city": "London",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        119],
       "assets/images/resized/0011/7147/117147v1-max-150x150.jpg"],
      [[250,
        199],
       "assets/images/resized/0011/7147/117147v1-max-250x250.jpg"],
      [[450,
        359],
       "assets/images/resized/0011/7147/117147v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}